Pediatrix Medical Group (NYSE:MD) Earns Hold (C) Rating from Weiss Ratings

Key Points

• Pediatrix Medical Group's stock holds a "hold (C)" rating as reaffirmed by Weiss Ratings, with an average rating of "Hold" and a consensus target price of $16.79.
• The company's shares recently opened at $17.12, experiencing a 2.7% decline, while its market cap stands at $1.49 billion.
• Pediatrix reported a quarterly EPS of $0.53, exceeding estimates, but its revenue fell 7.1% year-over-year to $468.84 million.

Pediatrix Medical Group (NYSE:MD - Get Free Report)'s stock had its "hold (c)" rating reaffirmed by investment analysts at Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.

Several other research analysts have also recently commented on MD. Leerink Partners raised their target price on Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a "market perform" rating in a research report on Friday, September 5th. Zacks Research upgraded Pediatrix Medical Group to a "strong-buy" rating in a research note on Monday, August 11th. Wall Street Zen upgraded Pediatrix Medical Group from a "buy" rating to a "strong-buy" rating in a research note on Saturday, October 4th. Finally, UBS Group increased their price objective on Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a "neutral" rating in a research note on Thursday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, Pediatrix Medical Group has an average rating of "Hold" and a consensus target price of $16.79.

Pediatrix Medical Group Stock Down 2.7%

Shares of MD stock opened at $17.12 on Wednesday. The stock has a market cap of $1.49 billion, a P/E ratio of 13.27 and a beta of 1.26. Pediatrix Medical Group has a one year low of $11.59 and a one year high of $18.22. The stock has a fifty day moving average price of $16.12 and a 200 day moving average price of $14.48. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.80 and a quick ratio of 1.80.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.42 by $0.11. The firm had revenue of $468.84 million during the quarter, compared to analysts' expectations of $464.37 million. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.Pediatrix Medical Group's quarterly revenue was down 7.1% compared to the same quarter last year. During the same period last year, the business earned $0.34 earnings per share. Analysts predict that Pediatrix Medical Group will post 1.38 earnings per share for the current year.

Institutional Trading of Pediatrix Medical Group

A number of hedge funds and other institutional investors have recently made changes to their positions in MD. GAMMA Investing LLC increased its stake in shares of Pediatrix Medical Group by 4,530.0% in the first quarter. GAMMA Investing LLC now owns 37,225 shares of the company's stock valued at $539,000 after buying an additional 36,421 shares in the last quarter. SG Americas Securities LLC increased its stake in shares of Pediatrix Medical Group by 194.0% in the first quarter. SG Americas Securities LLC now owns 38,405 shares of the company's stock valued at $556,000 after buying an additional 25,343 shares in the last quarter. SummerHaven Investment Management LLC increased its stake in shares of Pediatrix Medical Group by 0.9% in the first quarter. SummerHaven Investment Management LLC now owns 112,327 shares of the company's stock valued at $1,628,000 after buying an additional 1,028 shares in the last quarter. Ritholtz Wealth Management increased its stake in shares of Pediatrix Medical Group by 73.7% in the first quarter. Ritholtz Wealth Management now owns 24,119 shares of the company's stock valued at $349,000 after buying an additional 10,236 shares in the last quarter. Finally, Diversified Trust Co acquired a new stake in shares of Pediatrix Medical Group in the first quarter valued at $236,000. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.